This audio is auto-generated. Please let us know if you have feedback.
By the numbers
Q3 sales: $21.35 billion
6.8% increase year-over-year
Net income: $4.31 billion
Flat year-over-year
Medtech sales: $7.46 billion
10% increase year-over-year
Orthopaedics restructuring
Johnson & Johnson announced it will restructure its orthopedics business, with plans to exit less profitable markets and product lines, CFO Joe Wolk said during the companys third-quarter earnings call on Tuesday. The changes are intended to improve the growth and profitability of the segment, Wolk said.
The two-year restructuring program is expected to cost between $700 million and $800 million, including $235 million in costs du…
Read the full article at: https://www.medtechdive.com/news/jnj-q3-earnings-orthopedics-restructure/696798/